Blog

Mar 17, 2024, 19:28

The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 – 3P Solution

3P Solution shared a post on LinkedIn:

“Great news coming up!
We are organizing the first edition of the I.N.N.O.V.A.T.E congress – INTERNATIONAL NEOADJUVANT IMMUNOTHERAPY ACROSS CANCERS – that will be held in Naples on July 11th and 12th, 2024.

With this global meeting, we seek to bring together researchers engaged in neoadjuvant immunotherapy clinical and translational research with the goal of highlighting clinical advances, innovative research approaches, as well as possibilities for collaboration and opportunities to harmonize approaches across cancers.

The meeting will take place over two days and will consist of invited speakers, abstract presentations, and panel discussions. Topics will range from disease specific field overviews, pathology, biomarkers, imaging, and patient reported outcomes. Thanks to the Presidency: Paolo Ascierto, Prof Christian Blank, Liz Burton. Stay tuned for the next updates!“

The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 - 3P Solution

Source: 3P Solution/LinkedIn

3P Solution biomarkers cancer I.N.N.O.V.A.T.E congress Imaging immunotherapy Liz Burton Naples neoadjuvant immunotherapy OncoDaily Oncology Paolo A. Ascierto Pathology patient reported outcomes Prof Dr Christian Blank

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage